ClinicalTrials.govpublic full text
Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis
multiple sclerosis, multiple sclerosis, ms, cns, daclizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906929
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.